Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-16 Sale | 2020-03-18 6:00 pm | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $45.16 | $478,521 | 91,896 (Direct) | View |
| 2020-02-18 Sale | 2020-02-20 6:52 pm | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $46.61 | $493,850 | 102,491 (Direct) | View |
| 2020-01-15 Sale | 2020-01-16 6:01 pm | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $46.95 | $497,441 | 113,086 (Direct) | View |
| 2019-12-16 Sale | 2019-12-18 6:00 pm | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $47.23 | $500,351 | 123,681 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-04-02 Disposition | 2020-04-03 09:01 am | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 14,492 | $48 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:01 am | N/A 2026-08-16 | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 380,680 | $0 | 0 (Direct) | View |
| 2020-03-16 Exercise | 2020-03-18 6:00 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $5.6 | 91,896 (Direct) | View |
| 2020-03-16 Exercise | 2020-03-18 6:00 pm | N/A 2026-08-16 | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $0 | 91,896 (Direct) | View |
| 2020-02-18 Exercise | 2020-02-20 6:52 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $5.6 | 102,491 (Direct) | View |
| 2020-02-18 Exercise | 2020-02-20 6:52 pm | N/A 2026-08-16 | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $0 | 102,491 (Direct) | View |
| 2020-01-15 Exercise | 2020-01-16 6:01 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $5.6 | 113,086 (Direct) | View |
| 2020-01-15 Exercise | 2020-01-16 6:01 pm | N/A 2026-08-16 | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $0 | 113,086 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 6:00 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $5.6 | 123,681 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 6:00 pm | N/A 2026-08-16 | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $0 | 123,681 (Direct) | View |